Results 201 to 210 of about 94,046 (310)
TCPL, a transfersome with Tween 80 and PEI, enables efficient transdermal siNF‐κB delivery, resolving PEI's toxicity issue. It promotes lysosomal escape and effective transfection, silences NF‐κB, modulates immunity, and inhibits angiogenesis, alleviating psoriasis. With good biocompatibility, TCPL holds strong clinical translation potential. Schematic
Hui Xing +6 more
wiley +1 more source
Mechanistic Modelling of Transdermal Delivery Dependence on Drug Properties. [PDF]
Benbrook N, Zhan W.
europepmc +1 more source
ABSTRACT Background Coronary artery disease (CAD) with severe calcification remains a growing challenge in percutaneous coronary intervention (PCI). Atherectomy (ATH) has long been used for plaque modification, whereas intravascular lithotripsy (IVL) has emerged as a promising alternative. Large‐scale comparative data on long‐term outcomes are limited.
Charles D. Miks +3 more
wiley +1 more source
Polymeric Membrane-Based Systems in Transdermal Drug Delivery. [PDF]
Donato L, Bernardo P.
europepmc +1 more source
ABSTRACT Background Adverse events after acute myocardial infarction (AMI) are individually associated with poor outcomes, but the prognostic impact of the overlap of different event types occurring sequentially within the same patient remains uncertain.
Kyung Hoon Roh +12 more
wiley +1 more source
Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer. [PDF]
Oluwatola O +15 more
europepmc +1 more source
ABSTRACT Endovascular treatment (EVT) for chronic total occlusion (CTO) lesions has progressed recently; however, severely calcified lesions remain difficult to treat owing to challenges in guidewire passage and limited balloon or stent expansion. We report the case of a 79‐year‐old Asian male with intermittent claudication who had previously undergone
Kosei Tanaka +3 more
wiley +1 more source
Analgesic efficacy in women and men with cancer pain, treated with strong opioids: are there differences? [PDF]
Corli O +6 more
europepmc +1 more source

